Chemotherapy and Targeted Therapy

Clinical Uncertainty Clouds Edgewise Therapeutics’ Latest Heart Drug Data

• Chemotherapy and Targeted Therapy

Clinical Uncertainty Clouds Edgewise Therapeutics’ Latest Heart Drug Data

Raul Delapena Setiawan June 17, 2026

By Jonathan Gardner Published June 16, 2026 The cardiovascular therapeutic landscape remains in a state of high-stakes...

Read More Read more about Clinical Uncertainty Clouds Edgewise Therapeutics’ Latest Heart Drug Data

The Battle Over the Prescription Counter: Tennessee’s FAIR Rx Act Faces Legal Firestorm

• Chemotherapy and Targeted Therapy

The Battle Over the Prescription Counter: Tennessee’s FAIR Rx Act Faces Legal Firestorm

Nila Kartika Wati June 16, 2026

The landscape of the American pharmaceutical supply chain is undergoing a seismic shift as state governments attempt...

Read More Read more about The Battle Over the Prescription Counter: Tennessee’s FAIR Rx Act Faces Legal Firestorm

The Decade-Long Evolution: How Functional NAMs Are Revolutionizing Cardiac Safety Assessment

• Chemotherapy and Targeted Therapy

The Decade-Long Evolution: How Functional NAMs Are Revolutionizing Cardiac Safety Assessment

Dwi Wanna June 16, 2026

In the high-stakes world of pharmaceutical development, the shift away from traditional animal-based testing has often been...

Read More Read more about The Decade-Long Evolution: How Functional NAMs Are Revolutionizing Cardiac Safety Assessment

From Pandemic Giant to Oncology Pioneer: BioNTech’s High-Stakes Pivot

• Chemotherapy and Targeted Therapy

From Pandemic Giant to Oncology Pioneer: BioNTech’s High-Stakes Pivot

Lina Hope June 16, 2026

In the annals of biotechnology, few companies have experienced a rise as meteoric—or a transition as jarring—as...

Read More Read more about From Pandemic Giant to Oncology Pioneer: BioNTech’s High-Stakes Pivot

Bridging the Gap: Mastering the Strategic Pivot from Lab to Clinic for Injectable Drugs

• Chemotherapy and Targeted Therapy

Bridging the Gap: Mastering the Strategic Pivot from Lab to Clinic for Injectable Drugs

Ali Ikhwan June 16, 2026

For biopharmaceutical developers, the moment an injectable molecule moves from the laboratory bench to the clinical trial...

Read More Read more about Bridging the Gap: Mastering the Strategic Pivot from Lab to Clinic for Injectable Drugs

Protecting Innovation in a Borderless Pharma Economy: The New Frontier of Globalized IP Strategy

• Chemotherapy and Targeted Therapy

Protecting Innovation in a Borderless Pharma Economy: The New Frontier of Globalized IP Strategy

Nila Kartika Wati June 16, 2026

In the modern pharmaceutical landscape, the journey of a drug from a laboratory bench to a patient’s...

Read More Read more about Protecting Innovation in a Borderless Pharma Economy: The New Frontier of Globalized IP Strategy

Eli Lilly’s New Myelofibrosis Candidate Challenges Incyte’s Dominance

• Chemotherapy and Targeted Therapy

Eli Lilly’s New Myelofibrosis Candidate Challenges Incyte’s Dominance

Nila Kartika Wati June 15, 2026

By Jacob Bell | June 15, 2026 Eli Lilly’s strategic bet on the biotech startup Ajax Therapeutics...

Read More Read more about Eli Lilly’s New Myelofibrosis Candidate Challenges Incyte’s Dominance

FDA Commissioner Marty Makary Resigns Amidst Administrative Pressure and Policy Turmoil

• Chemotherapy and Targeted Therapy

FDA Commissioner Marty Makary Resigns Amidst Administrative Pressure and Policy Turmoil

Iffa Jayyana June 15, 2026

WASHINGTON, D.C. — In a development that signals a profound shift in the regulatory landscape of the...

Read More Read more about FDA Commissioner Marty Makary Resigns Amidst Administrative Pressure and Policy Turmoil

Beyond the Plate: The Evolving Landscape of Celiac Disease Therapy

• Chemotherapy and Targeted Therapy

Beyond the Plate: The Evolving Landscape of Celiac Disease Therapy

Lina Irawan June 15, 2026

For the estimated one in 100 people worldwide living with celiac disease, the diagnosis is not merely...

Read More Read more about Beyond the Plate: The Evolving Landscape of Celiac Disease Therapy

The Paradox of Progress: Why Pharmaceutical Sustainability Goals Are Struggling Against Rising Emissions

• Chemotherapy and Targeted Therapy

The Paradox of Progress: Why Pharmaceutical Sustainability Goals Are Struggling Against Rising Emissions

Neng Nana June 15, 2026

The global healthcare sector, long viewed as a bastion of wellness and life-saving innovation, is confronting an...

Read More Read more about The Paradox of Progress: Why Pharmaceutical Sustainability Goals Are Struggling Against Rising Emissions